ALT
Altimmune Inc
3.10$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -89.8% | -86.5% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +420.0% | -100.0% | – | – | |
| – | -89.7% | -94.3% | -43.0% | -39.3% | -10.8% | – | – | +49,766.7% | -99.8% | -11.5% | +0.0% | – | |
| – | – | -375.7% | – | +0.0% | +0.0% | +0.0% | +0.0% | -299,200.0% | – | -188.5% | – | – | |
| – | -8.0% | +27.1% | -1.5% | -6.4% | -0.1% | -20.0% | +8.9% | -13.2% | +23.1% | -12.2% | +15.4% | – | |
| – | -4.0% | +22.6% | +5.3% | -11.2% | +2.4% | +17.7% | -5.0% | +3.7% | +78.0% | -23.4% | -5.9% | – | |
| – | +645.7% | -20.7% | +0.2% | -7.4% | +0.4% | -12.3% | +5.1% | -74.2% | +389.8% | -16.2% | +8.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -93.1% | -50.0% | +0.0% | +500.0% | -83.3% | +0.0% | +26,300.0% | +87.5% | +77.0% | +21.9% | +2.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +234.5% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.